Page last updated: 2024-10-27

fluorouracil and Capillary Leak Syndrome

fluorouracil has been researched along with Capillary Leak Syndrome in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Capillary Leak Syndrome: A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.

Research Excerpts

ExcerptRelevanceReference
"Colorectal cancer is the third most common cancer diagnosed in the USA each year."1.43Systemic capillary leak syndrome in a patient receiving adjuvant oxaliplatin for locally advanced colon cancer. ( Anderson, BJ; Peterson, LL, 2016)
"The patient developed systemic capillary leak syndrome during the 16th cycle of chemotherapy."1.40Trastuzumab-induced systemic capillary leak syndrome in a breast cancer patient. ( Li, Z; Yang, J; Zhang, F, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, F1
Yang, J1
Li, Z1
Anderson, BJ1
Peterson, LL1

Other Studies

2 other studies available for fluorouracil and Capillary Leak Syndrome

ArticleYear
Trastuzumab-induced systemic capillary leak syndrome in a breast cancer patient.
    Pathology oncology research : POR, 2014, Volume: 20, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms;

2014
Systemic capillary leak syndrome in a patient receiving adjuvant oxaliplatin for locally advanced colon cancer.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Colorectal Neoplasms; Fluor

2016